369 related articles for article (PubMed ID: 38008185)
1. In situ cellular hitchhiking of nanoparticles for drug delivery.
Udofa E; Zhao Z
Adv Drug Deliv Rev; 2024 Jan; 204():115143. PubMed ID: 38008185
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles.
Anselmo AC; Mitragotri S
J Control Release; 2014 Sep; 190():531-41. PubMed ID: 24747161
[TBL] [Abstract][Full Text] [Related]
3. Cell-based carrier for targeted hitchhiking delivery.
Liu T; Gao C; Gu D; Tang H
Drug Deliv Transl Res; 2022 Nov; 12(11):2634-2648. PubMed ID: 35499717
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Nanocarrier design-function relationship: The prodigious role of properties in regulating biocompatibility for drug delivery applications.
Oladipo AO; Lebelo SL; Msagati TAM
Chem Biol Interact; 2023 May; 377():110466. PubMed ID: 37004951
[TBL] [Abstract][Full Text] [Related]
6.
Cevaal PM; Ali A; Czuba-Wojnilowicz E; Symons J; Lewin SR; Cortez-Jugo C; Caruso F
ACS Nano; 2021 Mar; 15(3):3736-3753. PubMed ID: 33600163
[TBL] [Abstract][Full Text] [Related]
7. Engineering cells for precision drug delivery: New advances, clinical translation, and emerging strategies.
Chao CJ; Zhang E; Zhao Z
Adv Drug Deliv Rev; 2023 Jun; 197():114840. PubMed ID: 37088403
[TBL] [Abstract][Full Text] [Related]
8. Renal clearable nanocarriers: Overcoming the physiological barriers for precise drug delivery and clearance.
Peng C; Huang Y; Zheng J
J Control Release; 2020 Jun; 322():64-80. PubMed ID: 32194171
[TBL] [Abstract][Full Text] [Related]
9. Disposition of nanoparticle-based delivery system via inner ear administration.
Chen G; Zhang X; Yang F; Mu L
Curr Drug Metab; 2010 Dec; 11(10):886-97. PubMed ID: 21208174
[TBL] [Abstract][Full Text] [Related]
10. Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review.
Wei W; Zhang Y; Lin Z; Wu X; Fan W; Chen J
J Drug Target; 2023 Jan; 31(1):1-13. PubMed ID: 35857432
[TBL] [Abstract][Full Text] [Related]
11. Emerging methods in therapeutics using multifunctional nanoparticles.
Habibi N; Quevedo DF; Gregory JV; Lahann J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1625. PubMed ID: 32196991
[TBL] [Abstract][Full Text] [Related]
12. A novel strategy to achieve effective drug delivery: exploit cells as carrier combined with nanoparticles.
Pang L; Zhang C; Qin J; Han L; Li R; Hong C; He H; Wang J
Drug Deliv; 2017 Nov; 24(1):83-91. PubMed ID: 28155538
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery.
Chavanpatil MD; Khdair A; Panyam J
J Nanosci Nanotechnol; 2006; 6(9-10):2651-63. PubMed ID: 17048473
[TBL] [Abstract][Full Text] [Related]
14. Targeted Drug Delivery - From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives.
Tewabe A; Abate A; Tamrie M; Seyfu A; Abdela Siraj E
J Multidiscip Healthc; 2021; 14():1711-1724. PubMed ID: 34267523
[TBL] [Abstract][Full Text] [Related]
15. Optimal delivery strategies for nanoparticle-mediated mRNA delivery.
Li X; Guo X; Hu M; Cai R; Chen C
J Mater Chem B; 2023 Mar; 11(10):2063-2077. PubMed ID: 36794598
[TBL] [Abstract][Full Text] [Related]
16. Biomimetic camouflage delivery strategies for cancer therapy.
Asrorov AM; Gu Z; Li F; Liu L; Huang Y
Nanoscale; 2021 May; 13(19):8693-8706. PubMed ID: 33949576
[TBL] [Abstract][Full Text] [Related]
17. Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers.
Brenner JS; Mitragotri S; Muzykantov VR
Annu Rev Biomed Eng; 2021 Jul; 23():225-248. PubMed ID: 33788581
[TBL] [Abstract][Full Text] [Related]
18. Challenges in development of nanoparticle-based therapeutics.
Desai N
AAPS J; 2012 Jun; 14(2):282-95. PubMed ID: 22407288
[TBL] [Abstract][Full Text] [Related]
19. Commentary: Nanoparticle-Based Chemotherapy Delivery and Potential Health Risks: Prospects for Effective Clinical Translation.
Assefa D; Melaku T; Alemu S
Technol Cancer Res Treat; 2023; 22():15330338231220171. PubMed ID: 38130152
[TBL] [Abstract][Full Text] [Related]
20. Untangling Mucosal Drug Delivery: Engineering, Designing, and Testing Nanoparticles to Overcome the Mucus Barrier.
Watchorn J; Clasky AJ; Prakash G; Johnston IAE; Chen PZ; Gu FX
ACS Biomater Sci Eng; 2022 Apr; 8(4):1396-1426. PubMed ID: 35294187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
